FMACX
Price
$41.74
Change
-$0.11 (-0.26%)
Updated
May 9 closing price
Net Assets
84.6B
RGAHX
Price
$71.62
Change
-$0.09 (-0.13%)
Updated
May 9 closing price
Net Assets
285.48B
Ad is loading...

FMACX vs RGAHX

Header iconFMACX vs RGAHX Comparison
Open Charts FMACX vs RGAHXBanner chart's image
American Funds AMCAP F3
Price$41.74
Change-$0.11 (-0.26%)
VolumeN/A
Net Assets84.6B
American Funds Growth Fund of Amer R5E
Price$71.62
Change-$0.09 (-0.13%)
VolumeN/A
Net Assets285.48B
FMACX vs RGAHX Comparison Chart
Loading...
View a ticker or compare two or three
VS
FMACX vs. RGAHX commentary
May 11, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FMACX is a Buy and RGAHX is a StrongBuy.

Ad is loading...
FUNDAMENTALS
Fundamentals
RGAHX has more cash in the bank: 285B vs. FMACX (84.6B). FMACX pays higher dividends than RGAHX: FMACX (0.64) vs RGAHX (0.54). FMACX was incepted earlier than RGAHX: FMACX (8 years) vs RGAHX (9 years). RGAHX (0.44) is less costly to investors than FMACX (0.34). FMACX is a more actively managed with annual turnover of: 27.00 vs. RGAHX (25.00). RGAHX has a lower initial minimum investment than FMACX: RGAHX (250) vs FMACX (1000000). RGAHX annual gain was more profitable for investors over the last year : 3.25 vs. FMACX (0.26). RGAHX return over 5 years is better than : 44.87 vs. FMACX (32.97).
FMACXRGAHXFMACX / RGAHX
Total Expense Ratio0.340.4477%
Annual Report Gross Expense Ratio0.340.4477%
Fund Existence8 years9 years-
Gain YTD-3.133-2.478126%
Front LoadN/AN/A-
Min. Initial Investment1000000250400,000%
Min. Initial Investment IRAN/AN/A-
Net Assets84.6B285B30%
Annual Yield % from dividends0.640.54118%
Returns for 1 year0.263.258%
Returns for 3 years26.9633.4081%
Returns for 5 years32.9744.8773%
Returns for 10 yearsN/AN/A-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ARKO4.770.32
+7.19%
ARKO Corp
LYRA0.10N/A
+4.03%
Lyra Therapeutics
JJSF116.230.49
+0.42%
J & J Snack Foods Corp
CRL138.79-2.57
-1.82%
Charles River Laboratories International
FDMT3.08-0.16
-4.94%
4D Molecular Therapeutics